Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model

被引:89
作者
Gombar, VK [1 ]
Polli, JW [1 ]
Humphreys, JE [1 ]
Wring, SA [1 ]
Serabjit-Singh, CS [1 ]
机构
[1] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA
关键词
absorption; blood-brain barrier; metabolism; multi-drug resistance; P-glycoprotein; QSAR; transporter;
D O I
10.1002/jps.20035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A quantitative structure-activity relationship (QSAR) model has been developed to predict whether a given compound is a P-glycoprotein (Pgp) substrate or not. The training set consisted of 95 compounds classified as substrates or non-substrates based on the results from in vitro monolayer efflux assays. The two-group linear discriminant model uses 27 statistically significant, information-rich structure quantifiers to compute the probability of a given structure to be a Pgp substrate. Analysis of the descriptors revealed that the ability to partition into membranes, molecular bulk, and the counts and electrotopological values of certain isolated and bonded hydrides are important structural attributes of substrates. The model fits the data with sensitivity of 100% and specificity of 90.6% in the jackknifed cross-validation test. A prediction accuracy of 86.2% was obtained on a test set of 58 compounds. Examination of the eight "mispredicted" compounds revealed two distinct categories. Five mispredictions were explained by experimental limitations of the efflux assay; these compounds had high permeability and/or were inhibitors of calcein-AM transport. Three mispredictions Were due to limitations of the chemical space covered by the current model. The Pgp QSAR model provides an in silico screen to aid in compound selection and in vitro efflux assay prioritization. (C) 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:957-968, 2004.
引用
收藏
页码:957 / 968
页数:12
相关论文
共 50 条
[41]   P-GLYCOPROTEIN STRUCTURE AND EVOLUTIONARY HOMOLOGIES [J].
CROOP, JM .
CYTOTECHNOLOGY, 1993, 12 (1-3) :1-32
[42]   A topological substructural approach for the prediction of P-glycoprotein substrates [J].
Cabrera, MA ;
González, I ;
Fernández, C ;
Navarro, C ;
Bermejo, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (03) :589-606
[43]   P-glycoprotein structure and evolutionary homologies [J].
Bosch, I ;
Croop, JM .
CYTOTECHNOLOGY, 1998, 27 (1-3) :1-30
[44]   P-glycoprotein structure and evolutionary homologies [J].
Irene Bosch ;
James M. Croop .
Cytotechnology, 1998, 27 :1-30
[45]   Stilbene analogues as inhibitors of breast cancer Stem cells through P-glycoprotein efflux; A 3D Quantitative Structure-Activity Relationship study (Inhibitory activity of stilbenes analogues on breast cancer stem cells) [J].
Tripathi, Anushree ;
Misra, Krishna .
2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2016,
[46]   Comparison of Quantitative Structure-Activity Relationship Model Performances on Carboquinone Derivatives [J].
Bolboaca, Sorana D. ;
Jaentschi, Lorentz .
THESCIENTIFICWORLDJOURNAL, 2009, 9 :1148-1166
[47]   Prediction of Terpenoid Toxicity Based on a Quantitative Structure-Activity Relationship Model [J].
Perestrelo, Rosa ;
Silva, Catarina ;
Fernandes, Miguel X. ;
Camara, Jose S. .
FOODS, 2019, 8 (12)
[48]   Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain [J].
Kothandana, Gugan ;
Gadhe, Changdev G. ;
Madhavan, Thirumurthy ;
Choi, Cheol Hee ;
Cho, Seung Joo .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) :4078-4088
[49]   A new structural model for P-glycoprotein [J].
Jones, PM ;
George, AM .
JOURNAL OF MEMBRANE BIOLOGY, 1998, 166 (02) :133-147
[50]   A PRACTICAL OVERVIEW OF QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP [J].
Nantasenamat, Chanin ;
Isarankura-Na-Ayudhya, Chartchalerm ;
Naenna, Thanakorn ;
Prachayasittikul, Virapong .
EXCLI JOURNAL, 2009, 8 :74-88